Author:
Manjón José V.,Romero José E.,Coupe Pierrick
Abstract
AbstractThe automatic assessment of hippocampus volume is an important tool in the study of several neurodegenerative diseases such as Alzheimer's disease. Specifically, the measurement of hippocampus subfields properties is of great interest since it can show earlier pathological changes in the brain. However, segmentation of these subfields is very difficult due to their complex structure and for the need of high-resolution magnetic resonance images manually labeled. In this work, we present a novel pipeline for automatic hippocampus subfield segmentation based on a deeply supervised convolutional neural network. Results of the proposed method are shown for two available hippocampus subfield delineation protocols. The method has been compared to other state-of-the-art methods showing improved results in terms of accuracy and execution time.
Funder
Ministerio de Economía, Industria y Competitividad, Gobierno de España
French National Research Agency
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Milner, B. Psychological defects produced by temporal lobe excision. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 36, 244–257 (1958).
2. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82(4), 239–259 (1991).
3. Jack, C. R. et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489 (2000).
4. Jack, C. R. et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65, 1227–1231 (2005).
5. Dickerson, B. C. & Sperling, R. A. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease. NeuroRx 2, 348–360 (2005).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献